Skip to main content

Table 1 Demographic and neuropsychiatric assessment data

From: Altered metabolic connectivity within the limbic cortico-striato-thalamo-cortical circuit in presymptomatic and symptomatic behavioral variant frontotemporal dementia

 

BvFTD patients

(n = 33)

Controls

(n =33)

Asymptomatic MAPT carriers

(n = 6)

Noncarriers in the family

(n = 12)

P-value

bvFTD patients

vs controls

P-value

MAPT carriers

vs noncarriers

Age

58.94 ± 9.87

55.82±10.05

49.00 ± 3.90

42.25 ± 9.21

0.20a

0.11a

Sex (male/female)

16/17

15/18

3/3

7/5

0.99c

0.99c

Years of education

10.62 ± 4.64

11.31 ±3.47

8.67 ± 0.52

10.55 ± 3.80

0.52a

0.25a

MMSE

16.52 ± 6.87

28.65 ± 2.07

28.67 ± 0.82

28.36 ± 2.06

<0.0001b

0.74a

MoCA

10.15 ± 6.25

26.06 ± 3.43

26.50 ± 1.23

26.18 ± 3.06

<0.0001b

0.81a

FTLD-CDR

10.98 ± 4.46

0 ± 0

0 ± 0

0 ± 0

<0.0001b

-

Memory

 AVLT: immediate recall

7.70 ± 7.38

23.81 ± 5.59

23.83 ± 2.32

26.00 ± 7.32

<0.0001a

0.50a

 AVLT: delayed recall

1.35 ± 2.53

8.79 ± 2.98

8.67 ± 2.25

9.27 ± 3.16

<0.0001a

0.69a

Executive function

 TMT-A

111.60±39.95

50.48 ± 24.94

44.33 ± 14.98

42.00 ±18.75

<0.0001b

0.79a

 TMT-B

247.80±82.95

88.44 ± 62.59

85.17 ± 35.37

63.67±31.04

<0.0001a

0.19a

Language

 BNT

11.63 ± 6.39

24.96 ± 3.83

25.00 ± 1.00

24.90 ± 2.08

<0.0001b

0.92a

Behavior features

 FBI total score

26.87 ± 14.94

1.67 ± 4.08

0 (0–6)

0 (0–2)

<0.0001b

0.84b

 FBI apathy

17.58 ± 9.02

0.83 ± 2.04

0 (0–4)

0 (0–0)

<0.0001b

0.40b

 FBI disinhibition

9.29 ± 7.88

0.83 ± 2.04

0 (0–2)

0 (0–1.5)

<0.001b

0.99b

  1. Data are presented as means ± the standard deviations or medians (Q1–Q3)
  2. AVLT auditory verbal learning test, BNT Boston Naming Test, FTLD-CDR Frontotemporal Lobar Degeneration-Clinical Dementia Rating, FBI Frontal Behavioral Inventory, MMSE Mini-Mental State Examination, MoCA Montreal Cognitive Assessment
  3. aBased on unpaired t-tests
  4. bBased on Mann-Whitney tests
  5. cBased on Pearson’s chi-squared test